Hf. Boyd et al., 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A(2), BIOORG MED, 10(4), 2000, pp. 395-398
Starting from two weakly active hits from high throughput screening, a nove
l series of 2-(alkylthio)-pyrimidin-4-ones with high potency and selectivit
y for lipoprotein-associated phospholipase Az has been designed. In contras
t to previously known inhibitors, these have been shown to act by a non-cov
alent and substrate competitive mechanism. (C) 2000 Elsevier Science Ltd. A
ll rights reserved.